feed,title,long_url,short_url
Benzinga,Belite Bio Starts Enrollment In Pivotal Lead Asset Study In Inherited Eye Disease,https://benzinga.com/general/biotech/22/08/28586113/belite-bio-starts-enrollment-in-pivotal-lead-asset-study-in-inherited-eye-disease,https://bit.ly/3T5y8KH
Benzinga,Gilead's Lenacapavir Scores European Approval For Pretreated HIV Patients After Manufacturing Delays,https://benzinga.com/general/biotech/22/08/28585444/gileads-lenacapavir-scores-european-approval-for-pretreated-hiv-patients-after-manufacturing-dela,https://bit.ly/3Tc95Wb
